Search results
Results from the WOW.Com Content Network
Ionis Pharmaceuticals Stock Price And Volume Action Ionis Pharmaceuticals (NASDAQ:IONS) is currently down 17.47% to a price of $46.29. Tuesday the stock has been traded at a volume of 2.55 million ...
Conversely, $2,309.60 per Fair Isaac share may appear expensive in comparison, with its much smaller earnings — about $6 in the most recent quarter — relative to share price.
TOKYO (Reuters) -U.S. private equity firm Bain Capital is set to raise its offer price for Japan's Fuji Soft to 9,600 yen ($63.35) per share, the Nikkei newspaper reported on W… Associated Press ...
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Here's what else happened today: Disney said it will appoint Bob Iger's successor as CEO by early 2026. Goldman Sachs said investors should prepare for a decade of muted returns in the stock market.
(For example, 500 shares at $32 may become 1000 shares at $16.) Many major firms like to keep their price in the $25 to $75 price range. A US share must be priced at $1 or more to be covered by NASDAQ. If the share price falls below that level, the stock is "delisted" and becomes an OTC (over the counter stock). A stock must have a price of $1 ...
US stocks rose Monday as investors await the Fed's interest rate decision on Wednesday. The Fed's final meeting of the year is expected to include a 25 basis points interest rate cut.
Stock market today: Dow soars 461 points while Nasdaq wavers as tech shares slip ... up 0.5% to $146.67 per share. The company reported another solid earnings beat, ... JPMorgan upped its price ...